Logo-npj
J Nephropharmacol. 2020;9(2): e21. doi: 10.34172/npj.2020.21

Epidemiology and Prevention

Drug therapy in hospitalized patients with very severe symptoms following COVID-19

Rohollah Valizadeh 1,2 ORCID, Nahid Dadashzadeh 3, Roya Zakeri 4, Steven James Kellner 5 ORCID, Mohsen Mohammad Rahimi 6 * ORCID

Cited by CrossRef: 7


1- Kouchek M, Shojaei S, Amniati S, Ghaffari M, Salarian S, Miri M, Taherpour N, Masbough F, Sistanizad M. Effect of High-dose Vitamin D on IL-1β Blood Level in Patients with Moderate Stroke: A Randomized Clinical Trial. Anesth Pain Med. 2023;13(4) [Crossref]
2- Gharebaghi N, Farshid S, Boroofeh B, Nejadrahim R, Mousavi J, Dindarian S, Mohammadi S. Evaluation of epidemiology, clinical features, prognosis, diagnosis and treatment outcomes of patients with COVID‐19 in West Azerbaijan Province. Int J Clinical Practice. 2021;75(6) [Crossref]
3- Taghizadieh A, Mikaeili H, Ahmadi M, Valizadeh H. Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran. Respiratory Medicine Case Reports. 2020;30:101090 [Crossref]
4- Lotfi B, Farshid S, Dadashzadeh N, Valizadeh R, Rahimi M. Is Coronavirus Disease 2019 (COVID-19) Associated with Renal Involvement? A Review of Century Infection. Jundishapur J Microbiol. 2020;13(4) [Crossref]
5- Ebrahimi H, Atashzadeh Shoorideh F, Reza Sohrabi M, Ebrahimi M, Hosseini M. An Analysis of Approaches to Reduction of HIV Stigma across the World through educational interventions: A Scoping Review. Invest Educ Enferm. 2024;42(1) [Crossref]
6- Kouchek M, Miri M, Aghakhani K, Memarian A. ABO blood group is related to the prevalence, severity, and mortality rate of COVID-19. Medicina Clínica Práctica. 2024;7(3):100442 [Crossref]
7- Nokhodian Z, Ranjbar M, Nasri P, Kassaian N, Shoaei P, Vakili B, Rostami S, Ahangarzadeh S, Alibakhshi A, Yarian F, Javanmard S, Ataei B. Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment. J Res Med Sci. 2020;25(1):101 [Crossref]